New Ventures
Many technologies are best suited to licensing but some could serve as the basis for starting a new company. OCR actively seeks to identify opportunities to form new business ventures. We develop business plans and strategies and identify seed-level funding sources for these ventures.
Yale New Venture Activities
- REN Pharmaceuticals
- BioRelix Pharmaceuticals
- Affomix Corporation
- Cystonix Pharmaceuticals
- Carigent Therapeutics
- Optherion, Inc
- Vidus Ocular, Inc.
